SHP-1 Regulates Antigen Cross-Presentation and Is Exploited by Leishmania to Evade Immunity
Intracellular pathogens have evolved strategies to evade detection by cytotoxic CD8+ T lymphocytes (CTLs). Here, we ask whether Leishmania parasites trigger the SHP-1-FcRγ chain inhibitory axis to dampen antigen cross-presentation in dendritic cells expressing the C-type lectin receptor Mincle. We f...
Saved in:
Published in | Cell reports (Cambridge) Vol. 33; no. 9; p. 108468 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.12.2020
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Intracellular pathogens have evolved strategies to evade detection by cytotoxic CD8+ T lymphocytes (CTLs). Here, we ask whether Leishmania parasites trigger the SHP-1-FcRγ chain inhibitory axis to dampen antigen cross-presentation in dendritic cells expressing the C-type lectin receptor Mincle. We find increased cross-priming of CTLs in Leishmania-infected mice deficient for Mincle or with a selective loss of SHP-1 in CD11c+ cells. The latter also shows improved cross-presentation of cell-associated viral antigens. CTL activation in vitro reveals increased MHC class I-peptide complex expression in Mincle- or SHP-1-deficient CD11c+ cells. Neuraminidase treatment also boosts cross-presentation, suggesting that Leishmania triggers SHP-1-associated sialic-acid-binding receptors. Mechanistically, enhanced antigen processing correlates with reduced endosomal acidification in the absence of SHP-1. Finally, we demonstrate that SHP-1 inhibition improves CD11c+ cell-based vaccination against the parasite. Thus, SHP-1-mediated impairment of cross-presentation can be exploited by pathogens to evade CTLs, and SHP-1 inhibition improves CTL responses during vaccination.
[Display omitted]
•Lack of Mincle or SHP-1 loss in CD11c+ cells raises CD8+ T cell priming to Leishmania•SHP-1 deficiency increases endosomal pH and enhances antigen cross-presentation•SHP-1 inhibition boosts CD11c+ cell-based vaccination efficacy against Leishmania
Khouili et al. identify SHP-1 as a negative regulator of antigen cross-presentation that Leishmania can trigger by interacting with Mincle and sialic-acid-binding receptors, dampening early CD8+ T cell recognition. Loss of functional SHP-1 in CD11c+ cells decreases endosomal acidification, increases cross-presentation, and boosts CD11c+ cell-based vaccination against Leishmania. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2020.108468 |